TGTGInsighttelegram intelligenceLIVE / telegram public index
← GitHub Trends

TGINSIGHT SIMILAR POSTS

Find similar content

Source channel @githubtrending · Post #15125 · Sep 7

#cplusplus#controller#gamepad#gamepad_api#games#gaming#keyboard_emulation AntiMicroX lets you use a gamepad to control your computer by mapping gamepad buttons to keyboard keys, mouse actions, scripts, or macros. It works on Linux and Windows, supports many gamepads, and allows you to create multiple profiles for different apps or games. This makes it easier to play games that don’t support controllers or to control desktop apps with a gamepad, improving comfort and accessibility. You can install it easily on various systems, including Windows, Linux (via Flatpak, AppImage, or package managers), and customize it to fit your needs. It’s open-source and free to use. https://github.com/AntiMicroX/antimicrox

Results

1 similar post found

Search: #signalprocessing

当前筛选 #signalprocessing清除筛选
Venture Village Wall 🦄

@venturevillagewall · Post #3912 · 01/18/2025, 10:00 AM

$51M Raised Across Multiple Startups Ten innovative startups secured funding in January 2025, totaling $51 million. Highlights include: - Merit Systems: $10M for an open-source economy. - Botika: $8M, leading in AI-generated fashion models. - Underdogs: $6.13M, focused on training entrepreneurs. - TrustUp: $5.18M in health tech innovation. - Elcogen: $5M in efficient fuel cell manufacturing. - Convergence Medical Robotics: $5M for medical robotics solutions. - Constelli: $3M in signal processing for defense. - Immunocure Discovery Solutions: $3M in AI drug discovery services. - Naco: $2.58M for nano coatings in fuel cells. - TalentMapper: $2.44M for talent management solutions. Read more: Merit Systems | Botika | Underdogs | TrustUp | Elcogen | Convergence Medical Robotics | Constelli | Immunocure Discovery Solutions | Naco | TalentMapper #StartupFunding#OpenSource#AI#FashionTech#Education#HealthTech#FuelCells#Innovation#SignalProcessing#DrugDiscovery#NanoTech#HydrogenEnergy#MedTech#VC